The Preclinical Validation of Radio-Labelled Girentuximab as a Theranostic Agent in Metastatic Colorectal Cancer

Carbonic Anhydrase-IX Is a Specific and Sensitive Theragnostic Target for Imaging and Radioimmunotherapy in Metastatic Colorectal Cancer

D Swaroop, J Smith, J Van Zuykelom, A Noor, RA Wagner, T Vu, S Lee, AG Heriot, B Loveday, K Waldeck, PD Roselt, B Blyth, PS Donnelly, F Hollande

2026-01-01

Background and Aims: Over 40% of colorectal cancer (CRC) patients develop metastatic disease. Their survival outlook is very low, ..